NERX Neorx (MM)

NeoRx CEO to Participate in Break-Out Session at Upcoming BIO 2005 Conference SEATTLE, June 16 /PRNewswire-FirstCall/ -- NeoRx Corporation (NASDAQ:NERX) today announced that Chairman and Chief Executive Officer Jerry McMahon, Ph.D., will speak on a panel at the Biotechnology Industry Organization (BIO) 2005 Annual International Convention, which is taking place June 19-22, at the Philadelphia Convention Center. The panel "Putting Translational Medicine Into Practice: Benefits and Challenges," is scheduled for Monday, June 20, from 9:30 - 10:45 a.m. Eastern Time during a BIO 2005 Break-Out Session in the "Cancer" track. The panel will highlight the role that translational medicine is playing in the development of rationally designed targeted therapeutics and address critical issues and different approaches that facilitate the clinical development of targeted cancer drugs. About NeoRx NeoRx is a cancer therapeutics development company. The Company currently is focusing its development efforts on picoplatin (NX 473), a next-generation platinum therapy that the Company plans to evaluate in the treatment of patients with advanced lung and colorectal cancers. For more information, visit http://www.neorx.com/. DATASOURCE: NeoRx Corporation CONTACT: Julie Rathbun of NeoRx Corporation, +1-206-286-2517, or Web site: http://www.neorx.com/

Copyright